Trulieve is set to become the first U.S. cannabis company listed on the New York Stock Exchange

The U.S. cannabis industry is set to reach a symbolic milestone this week, as Trulieve prepares to become the first U.S. cannabis operator to be listed on a major U.S. stock exchange.

The company will begin trading on the New York Stock Exchange (NYSE) under the ticker symbol TRLV on June 10.

A historic ranking made possible by the federal reclassification

This listing follows the rescheduling of cannabis last April, which removed cannabis from Schedule 1 of controlled substances and reclassified it as a Schedule 3 substance, recognizing its medical applications and, in particular, opening up banking and securities services to U.S. cannabis companies.

As Kim Rivers, CEO of Trulieve, stated, this decision represents a “common-sense move” that has enabled the company to embark on a new phase of growth and visibility in the public sector.

The company has also highlighted its operational scope as the basis for this rating, including in particular 206 health clinics and approximately 350,000 square meters of production capacity in Florida, Pennsylvania, or West Virginia.

To list on the NYSE, Trulieve undertook a structural reorganization, separating the parts of its business that operate in both the medical cannabis and recreational cannabis markets. The remaining listed entity will focus primarily on state-licensed medical cannabis operations.

This restructuring is essential to meet stock exchange requirements, as the sale of recreational cannabis remains prohibited at the federal level.

Investor access is expanding

This listing is expected to have immediate implications for the capital markets. U.S. cannabis stocks have long been confined to the over-the-counter market, which has limited liquidity and participation by institutional investors.

The leading cannabis ETF AdvisorShares Pure US Cannabis ETF (MSOS), which holds significant exposure to Trulieve, is also expected to adjust its portfolio structure as direct access to exchanges becomes available.

Stock market analysts suggest that this listing could gradually unlock institutional capital, particularly from funds that invest exclusively in NYSE-listed securities or on the Nasdaq.

Trulieve’s decision is already influencing its competitors. Companies such as Curaleaf and Verano have recently announced stock consolidations, a move often used to meet the minimum share price thresholds required for listing on major stock exchanges.